Triiodothyronine modulates growth, secretory function and androgen receptor concentration in the prostatic carcinoma cell line LNCaP

This publication has 24 references indexed in Scilit:

• Inhibition of tumorigenic potential and prostate‐specific antigen expression in LNCaP human prostate cancer cell line by 13‐cis‐retinoic acid
  International Journal of Cancer, 1994
• A serum‐free defined medium capable of supporting growth of four established human prostatic carcinoma cell lines
  The Prostate, 1994
• Triiodothyronine (T3) modulates hCG-regulated progesterone secretion, cAMP accumulation and DNA content in cultured human luteinized granulosa cells
  Molecular and Cellular Endocrinology, 1993
• Effect of Retinoic Acid on the Proliferation and Secretory Activity of Androgen-Responsive Prostatic Carcinoma Cells
  Journal of Urology, 1993
• Steroids inversely affect the biosynthesis and secretion of human prostatic acid phosphatase and prostate-specific antigen in the LNCaP cell line
  The Journal of Steroid Biochemistry and Molecular Biology, 1992
• Multiple Components of a Complex Androgen-Dependent Enhancer
  Molecular Endocrinology, 1991
• Nuclear tri-iodothyronine (T3) binding in neonatal rat brain suggests a direct glial requirement for T3 during development
  Journal of Endocrinology, 1990
• The prostate: An increasing medical problem
  The Prostate, 1990
• Androgen‐dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP
  The Prostate, 1986
• Triiodothyronine Receptors During Maturation
  Endocrinology, 1977